Breast Cancer Foundation NZ
Stereotactic brain radiotherapy
What is the problem and who is affected?
An estimated 30% of women with advanced breast cancer develop metastases in the brain, many of them likely to be younger women. Conventionally, patients with cancer that has spread to the brain receive radiation to the whole brain, which can cause negative cognitive effects. The incidence of brain metastases is increasing as new drugs allow women to live longer with their advanced breast cancer.
What is this research hoping to achieve?
Stereotactic radiotherapy delivers a high dose, highly precise burst of radiation to a very small area. It has better outcomes in controlling the cancer in the brain and in overall survival, and a much better cognitive outcome. As well as cancer that has spread to the brain, this treatment is also effective on metastases in the lungs, liver and bones.
-
DecemberBelinda Scott Fellowship
Search for TDP1 and TDP2 inhibitors
-
AugustResearch Grant
A clinical study using personalised blood tests to monitor tumour DNA
-
AugustResearch Grant
A screening test to determine which HER2+ breast cancer patients will benefit from Kadcyla
-
AugustResearch Grant
A new antibody targeting hard-to-treat cancers
-
AugustResearch Grant
A new test to identify patients who will suffer from severe side-effects on capecitabine
-
JuneResearch Grant
Using the Breast Cancer Foundation National Register for targeted molecular research
-
MayBelinda Scott Fellowship
An exploration into the gene that determines whether hormone therapy works for certain individuals
-
MayBelinda Scott Fellowship
An investigation into the potential of low-oxygen-targeted drugs as a treatment for breast cancer
-
MayResearch Grant
MAGLEV Study
-
MayResearch Grant
BCAR
-
MarchResearch Grant
ELIMINATE Trial
-
MarchMedical Equipment
Improving cardiac safety for breast cancer patients through a Deep Inspiration Breath Hold (DIBH)
-
MarchMedical Equipment
Stereotactic brain radiotherapy
-
FebruaryResearch Grant
Developing guidelines for breast conserving surgery
-
FebruaryResearch Grant
Exploring cell nucleus changes as drug targets for advanced breast cancer